Cargando…

Botulinum toxin for prevention of post-operative atrial fibrillation

Detalles Bibliográficos
Autores principales:	Saljic, Arnela, Hansen, Malthe Emil Høtbjerg, Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885901/ https://www.ncbi.nlm.nih.gov/pubmed/36715734 http://dx.doi.org/10.1007/s00210-023-02402-y

Ejemplares similares

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
por: Saljic, Arnela, et al.
Publicado: (2022)

Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023)

The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig: A case report
por: Saljic, Arnela, et al.
Publicado: (2022)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

3D-electroanatomical mapping of the left atrium and catheter-based pulmonary vein isolation in pigs: A practical guide
por: Hertel, Julie Norup, et al.
Publicado: (2023)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication
por: Barrios Espinosa, Cristian, et al.
Publicado: (2020)

Researchers in cardiology – Why and how to get on Twitter?
por: Benjamin Fyenbo, Daniel, et al.
Publicado: (2022)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
por: Gawałko, Monika, et al.
Publicado: (2020)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation
por: Song, Jia, et al.
Publicado: (2023)

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge
por: Riesinger, L., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need
por: Tsuji, Yukiomi, et al.
Publicado: (2021)

Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
por: Chen, Gong, et al.
Publicado: (2018)

Path to precision: prevention of post-operative atrial fibrillation
por: Skaria, Rinku, et al.
Publicado: (2020)

Botulinum Neurotoxins: From Toxin to Medicine
por: Santamato, Andrea
Publicado: (2023)

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications
por: Gawałko, Monika, et al.
Publicado: (2020)

Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
por: Wakili, Reza, et al.
Publicado: (2019)

Pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut reduces atrial fibrillation susceptibility in obese spontaneously hypertensive rats
por: Linz, Benedikt, et al.
Publicado: (2020)

In Silico Assessment of Efficacy and Safety of I(Kur) Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding
por: Ellinwood, Nicholas, et al.
Publicado: (2017)

In-depth characterization of a mouse model of postoperative atrial fibrillation
por: Keefe, Joshua A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p11kau2mvgue2cvh643mk79bpb